Validity of administrative data for the diagnosis of primary sclerosing cholangitis: A population-based study

Liver International

Volumn 31, Issue 5, 2011, Pages 712-720

  Molodecky, Natalie A ^a,b   Myers, Robert P ^a,b   Barkema, Herman W ^a   Quan, Hude ^a   Kaplan, Gilaad G ^a,b  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

Algorithms; Positive predictive value; Primary sclerosing cholangitis; Sensitivity; Validation

Indexed keywords

ADULT; ALGORITHM; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; COVARIANCE; DATA ANALYSIS; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; ENTERITIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MEDICAL RECORD REVIEW; MODEL; POPULATION RESEARCH; PREDICTIVE VALUE; PREDICTOR VARIABLE; PRIMARY SCLEROSING CHOLANGITIS; PROBABILITY; SENSITIVITY ANALYSIS; VALIDITY;

ADULT; AGED; ALBERTA; ALGORITHMS; BIOPSY; CHOLANGITIS, SCLEROSING; DATA MINING; DATABASES AS TOPIC; FEMALE; HUMANS; INTERNATIONAL CLASSIFICATION OF DISEASES; LOGISTIC MODELS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; ROC CURVE; TIME FACTORS;

EID: 79953294527     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2011.02484.x     Document Type: Article

References (26)

1. Saich R, Chapman R. Primary sclerosing cholangitis, autoimmune hepatitis and overlap syndromes in inflammatory bowel disease. World J Gastroenterol 2008; 14: 331-7.
2. Talwalkar JA, Lindor KD. Primary sclerosing cholangitis. Inflamm Bowel Dis 2005; 11: 62-72.
3. Lee Y-M, Kaplan MM. Primary sclerosing cholangitis. N Engl J Med 1995; 332: 924-33.
4. Loftus EV, Harewood GC, Loftus CG, et al. PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis. Gut 2005; 54: 91-6.
5. LaRusso NF, Shneider BL, Black D, et al. Primary sclerosing cholangitis: summary of a workshop. Hepatology 2006; 44: 746-64.
6. Silveira MG, Lindor KD. Primary sclerosing cholangitis. Can J Gastroenterol 2008; 22: 689-98.
7. Brandsaeter B, Schrumpf E, Bentdal O, et al. Recurrent primary sclerosing cholangitis after liver transplantation: a magnetic resonance cholangiography study with analyses of predictive factors. Liver Transpl 2005; 11: 1361-9.
8. Graziadei IW, Wiesner RH, Batts KP, et al. Recurrence of primary sclerosing cholangitis following liver transplantation. Hepatology 1999; 29: 1050-6.
9. Card TR, Solaymani-Dodaran M, West J. Incidence and mortality of primary sclerosing cholangitis in the UK: a population-based cohort study. J Hepatol 2008; 48: 939-44.
10. Boberg KM, Aadland E, Jahnsen J, Raknerud N, Stiris M, Bell H. Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population, 1998; 33: 99-103.
11. Bambha K, Kim WR, Talwalkar J, et al. Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a united states community. Gastroenterology 2003; 125: 1364-9.
12. Escorsell A, Parés A, Rodés J, et al. Epidemiology of primary sclerosing cholangitis in Spain. J Hepatol 1994; 21: 787-91.
13. Kingham JGC, Kochar N, Gravenor MB. Incidence, clinical patterns, and outcomes of primary sclerosing cholangitis in South Wales, United Kingdom. Gastroenterology 2004; 126: 1929-30.
14. Kaplan GG, Laupland KB, Butzner D, Urbanski SJ, Lee SS. The burden of large and small duct primary sclerosing cholangitis in adults and children: a population-based analysis. Am J Gastroenterol 2007; 102: 1042-9.
15. Wee A, Ludwig J. Pericholangitis in chronic ulcerative colitis: primary sclerosing cholangitis of the small bile ducts? Ann. Intern. Med. 1985; 102: 581-7.
16. Kochhar R, Goenka MK, Das K, et al. Primary sclerosing cholangitis: an experience from India. J Gastroenterol Hepatol 1996; 11: 429-33.
17. Nikolaidis NL, Giouleme OI, Tziomalos KA, et al. Small-duct primary sclerosing cholangitis. A single-center seven-year experience. Dig Dis Sci 2005; 50: 324-6.
18. Miloh T, Arnon R, Shneider B, Suchy F, Kerkar N. A retrospective single-center review of primary sclerosing cholangitis in children. Clin Gastroenterol Hepatol 2009; 7: 239-45.
19. Hurlburt KJ, McMahon BJ, Deubner H, et al. Prevalence of autoimmune liver disease in Alaska natives. Am J Gastroenterol 2002; 97: 2402-7.
20. Habior A, Walewska-Zielecka B, Butruk E. Variant forms of autoimmune liver diseases. Gastroenterol. Polska 2003; 10: 359-64.
21. Lee JG. Diagnosis and management of acute cholangitis. Nat Rev Gastroenterol Hepatol 2009; 6: 533-41.
22. Richards J. The Data Quality Study of the Canadian Discharge Abstract Database. Proceedings of the Statistics Canada International Symposium Series 2001. Available at (accessed 15 March 2009).
23. Hatcher J, Hervas M. Emigration patterns of cancer cases in Alberta, Canada. Chronic Dis Can 2001; 22: 12-7.
24. Myers RP, Shaheen AA, Fong A, Wan AF, et al. Validation of coding algorithms for the identification of patients with primary biliary cirrhosis using administrative data. Can J Gastroenterol 2010; 24: 175-82.
25. Bernstein CN, Blanchard JF, Rawsthorne P, Wajda A. Epidemiology of Crohn's disease and ulcerative colitis in a central Canadian province: a population-based study. Am J Epidemiol 1999; 149: 916-24.
26. Olsson R, Boberg KM, Schaffalitsky de Muckadell O, et al. High-dose Ursodeoxycholic acid in primary sclerosing Cholangitis: A 5-year multicenter, randomized, controlled study. Gastroenterology 2005; 129: 1464-72.